Literature DB >> 16585150

Using chemopreventive agents to enhance the efficacy of cancer therapy.

Fazlul H Sarkar1, Yiwei Li.   

Abstract

Emerging evidence suggests that cancer preventative agents might be combined with chemotherapy or radiotherapy for the more effective treatment of cancer. Recent studies suggest that genistein and other dietary compounds that prevent cancer may enhance the efficacy of cancer therapeutics by modifying the activity of key cell proliferation and survival pathways, such as those controlled by Akt, nuclear factor-kappaB, and cyclooxygenase-2. In this article, we summarize the findings of recent investigations of chemopreventive agents in combination with cancer treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585150     DOI: 10.1158/0008-5472.CAN-05-4526

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo.

Authors:  Hang Zhu; Hua Cheng; Yuan Ren; Zhan Guo Liu; Yi Fang Zhang; Bing De Luo
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.

Authors:  Sanjeev Banerjee; Asfar S Azmi; Subhash Padhye; Marjit W Singh; Jubaraj B Baruah; Philip A Philip; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

3.  FoxM1 is a novel target of a natural agent in pancreatic cancer.

Authors:  Zhiwei Wang; Aamir Ahmad; Sanjeev Banerjee; Asfar Azmi; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 4.  Mechanisms of combined action of different chemopreventive dietary compounds: a review.

Authors:  Theo M de Kok; Simone G van Breda; Margaret M Manson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

Review 5.  Forkhead box M1 transcription factor: a novel target for cancer therapy.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2009-12-22       Impact factor: 12.111

6.  Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes.

Authors:  Satya Sree N Kolar; Rola Barhoumi; Evelyn S Callaway; Yang-Yi Fan; Naisyin Wang; Joanne R Lupton; Robert S Chapkin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-08-23       Impact factor: 4.052

7.  Involvement of the phosphoinositide 3-kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1.

Authors:  Jian-Hong Zhang; Fu-Ji Lai; Hui Chen; Jiang Luo; Ri-Yuan Zhang; He-Qi Bu; Zhao-Hong Wang; Hong-Hai Lin; Sheng-Zhang Lin
Journal:  Oncol Lett       Date:  2012-10-24       Impact factor: 2.967

8.  Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

Authors:  El-Shaimaa A Arafa; Qianzheng Zhu; Bassant M Barakat; Gulzar Wani; Qun Zhao; Mohamed A El-Mahdy; Altaf A Wani
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

9.  A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy.

Authors:  Yoshitaka Nakamura; Shingo Yogosawa; Yasuyuki Izutani; Hirotsuna Watanabe; Eigo Otsuji; Tosiyuki Sakai
Journal:  Mol Cancer       Date:  2009-11-12       Impact factor: 27.401

10.  Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.

Authors:  Baoan Chen; Jian Cheng; Yanan Wu; Feng Gao; Wenlin Xu; Huilin Shen; Jiahua Ding; Chong Gao; Qian Sun; Xinchen Sun; Hongyan Cheng; Guohong Li; Wenji Chen; Ningna Chen; Lijie Liu; Xiaomao Li; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.